glp-1 inflammation reduction Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide | Cardiovascular Diabetology Glucagon-like peptide-1: a multi-faceted anti-inflammatory

GLP-1 weight loss medications such as semaglutide (Wegovy) and tirzepatide (Zepbound) may be effective for menopausal weight gain

Med Rev 2024;4(4):30111 29.Heymsfield SB, Gonzalez MC, Shen W, Redman L, Thomas D (2014) Weight loss composition is one-fourth fat-free mass: a critical review and critique of this widely cited rule

GLP-1 medicines induce substantial metabolic improvements in the liver, with reduction in liver weight and lipid accumulation largely attributed to weight loss

however, emerging evidence suggests a potential protective effect

Details of the registries and codes used for cancer diagnoses, drug exposure and covariates are provided in electronic supplementary material (ESM) Methods and ESM Tables 13